In my opinion (not a doctor or scientist), the valuation is more based on the rights and intellectual property (outside of financials). If their flagship cancer drug does anything to treat and extend lives for those with pancreatic cancer, it would be huge!!!!. I would guess the buyout proposals would be made.
News 
Market Data 
Discover 
